Read on Twitter
1/
Another solid piece of progress from #AVCT, that increases its long term investment attractiveness.
Looking at the venture capital investment participants, it indicates that Daewoongs efforts in Korea, have been instrumental in achieving such noteworthy participation,
Another solid piece of progress from #AVCT, that increases its long term investment attractiveness.
Looking at the venture capital investment participants, it indicates that Daewoongs efforts in Korea, have been instrumental in achieving such noteworthy participation,
2/
from the likes of Samsung and Shinhan, the second of which has an excellent visual on its website, demonstrating when it believes venture capital finance comes in and what it deems it should be employed for.
from the likes of Samsung and Shinhan, the second of which has an excellent visual on its website, demonstrating when it believes venture capital finance comes in and what it deems it should be employed for.
3/
In terms of the RNS, its great to read words like "expected" rather than hope. It along with this investment, tells me they must be very happy with what they have seen/achieved, in the first year of this joint venture (announced 3rd Feb 2020).
In terms of the RNS, its great to read words like "expected" rather than hope. It along with this investment, tells me they must be very happy with what they have seen/achieved, in the first year of this joint venture (announced 3rd Feb 2020).
4/
Whilst we investors clearly would love to understand the true progress of the 2 Covid related test products, its important to recognise that since the last Covid related update (23rd Nov), AVCT have closed...
Whilst we investors clearly would love to understand the true progress of the 2 Covid related test products, its important to recognise that since the last Covid related update (23rd Nov), AVCT have closed...
5/
1. 2 licensing agreements,
2. submitted their CTA for AVA6000,
3. agreed a collaboration with Bruker on the BAMS test
4. Closed $7.3m in venture capitalist funding for AffyCell
That's excellent progress and a demonstration of the interest and indeed confidence,
1. 2 licensing agreements,
2. submitted their CTA for AVA6000,
3. agreed a collaboration with Bruker on the BAMS test
4. Closed $7.3m in venture capitalist funding for AffyCell
That's excellent progress and a demonstration of the interest and indeed confidence,
6/
that outside entities are demonstrating in the Affimer platform.
Yes it will take time to come to fruition but when added to the other partnerships, with the likes of LG Chem and Moderna, there's many pies to be had and any one success, can deliver a really big result here.
that outside entities are demonstrating in the Affimer platform.
Yes it will take time to come to fruition but when added to the other partnerships, with the likes of LG Chem and Moderna, there's many pies to be had and any one success, can deliver a really big result here.
6A
As a reminder, here's a short video #AVCT on the joint venture with Daewoong and what it is attempting to do. https://avacta.com/alastair-smith-provides-update-on-affyxell-collaboration-and-licence-agreement/
As a reminder, here's a short video #AVCT on the joint venture with Daewoong and what it is attempting to do. https://avacta.com/alastair-smith-provides-update-on-affyxell-collaboration-and-licence-agreement/
